Diagnosis and Understanding Your Biopsy Report
At a Glance
A skin papilloma is often benign, but a changing, bleeding, or unclear growth may need dermoscopy and biopsy. The pathology report identifies the tissue pattern, while your dermatologist determines whether the result matches the growth and whether follow-up is needed.
When you visit a dermatologist for a skin growth, the goal is to move from a broad description like “papilloma” to a precise diagnosis. This journey often involves a combination of high-tech magnification and, in some cases, a laboratory analysis of the tissue itself.
Understanding this process helps you interpret the results and ensures you are receiving a thorough evaluation.
The First Step: Dermoscopy
Before reaching for a scalpel, your doctor will likely use a dermoscope—a handheld device that uses polarized light and high magnification to see structures beneath the skin’s surface [1][2].
Dermoscopy allows doctors to look for specific “clues” that differentiate a benign papilloma from more serious concerns:
- Benign Warts: These often show a pattern of dotted blood vessels on a yellow or brown background [1].
- Seborrheic Keratoses: These common mimics typically show “milia-like cysts” (tiny white spots) and “fissures and ridges” that look like the surface of a brain [3].
- Warning Signs: If the doctor sees irregular blood vessels, “white circles” around hair follicles, or “arborizing vessels” (which look like tree branches), they may suspect a skin cancer like squamous cell carcinoma (SCC) or basal cell carcinoma (BCC) and recommend a biopsy [4][5][6].
When is a Biopsy Necessary?
A biopsy is usually recommended if the growth is changing, bleeding, or if the dermoscopic exam is inconclusive [7][8]. Note that for an obvious, typical skin tag, the clinician may simply snip it off without needing a formal diagnostic biopsy. The method of biopsy chosen depends on the suspected tumor, size, and location of the growth:
- Shave Biopsy: The doctor uses a small blade to “shave” off the growth and a thin layer of the skin beneath it. This is commonly used for suspected superficial keratinocyte cancers or skin tags [9].
- Punch Biopsy: A circular tool (like a tiny cookie cutter) removes a “plug” of skin. This is used when the doctor needs to see the deeper layers of the skin [10].
- Excisional Biopsy: The entire growth is removed along with a small margin of healthy skin. This is often preferred when a melanoma is suspected, to allow complete assessment [11][12].
What to expect: The area will be numbed with a local anesthetic. Afterward, you will have a small wound that requires basic care (keeping it clean and covered). Your doctor will tell you when to expect results and when to call if you experience excessive bleeding or signs of infection.
Why Depth Matters
For certain types of “warty” growths, a superficial shave is not enough. Rare but invasive variants, such as carcinoma cuniculatum, grow deep into the tissue with “keratin-filled crypts” (rabbit-burrow-like tunnels) [13]. A biopsy that is too shallow may miss these deep roots, leading to a false “benign” result [14][10].
Decoding Your Pathology Report
Once the tissue is analyzed, you will receive a pathology report. This document uses specific technical terms to describe what was seen under the microscope. We recommend you interpret the entire report with your treating clinician:
- Exophytic: This means the growth is “pushing outward” from the skin surface [15][16]. However, a lesion can be exophytic and still have an invasive component beneath the surface.
- Stratified Squamous Epithelium: This is the medical term for the layers of flat, protective cells that make up your outer skin [15].
- Fibrovascular Core: The “scaffolding” of the growth, made of connective tissue and blood vessels that “feed” the papilloma [17][18].
- Hyperkeratosis: A thickening of the outermost “dead” layer of skin (keratin), which gives warts their rough texture [19].
- Koilocytes: These are “hollowed-out” looking cells that can support an HPV-related change [20][15]. However, they do not by themselves prove an active, transmissible infection or identify the HPV type.
Discussing the Results with Your Doctor
Rather than viewing these as absolute requirements for a valid report, use these questions to discuss the results with your clinician:
- Clear Diagnosis: Ask the doctor to explain the exact diagnosis rather than just “benign skin” [12].
- Margin Status: If the growth was removed, does the report state whether the margins (the edges) are “clear” or “involved”? [12]. Note that for a superficial shave or a benign skin tag, margins may not be reported or clinically important.
- Benign vs. Dysplasia: Ask if the report mentions “atypia” or “dysplasia.” These are context-dependent terms; they are not interchangeable in every skin or mucosal site, and do not automatically mean cancer [21][22].
- Clinical Correlation: Does the lab’s finding match what the doctor saw on your body? Clinical-pathologic discordance determines whether repeat sampling is needed [23][18].
If your growth returns or continues to change after a “benign” report, always follow up with your doctor. Most recurrences have common explanations like incomplete removal or a persistent wart, but repeat or deeper sampling may occasionally be necessary [24][10].
Common questions in this guide
Why would a skin papilloma need a biopsy?
What type of biopsy is used for a skin papilloma?
What do the terms in a skin papilloma pathology report mean?
Do koilocytes mean my skin papilloma is contagious?
What do clear margins, atypia, and dysplasia mean on my report?
What if the skin growth returns after a benign biopsy?
One line in your results can change your plan.
Whether the lab finding matches what the doctor saw determines whether repeat sampling is needed. We check your results against the latest research to help you prepare for what’s next.
Get notified when new evidence is published on skin papilloma.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
References
References (24)
- 1
Clinical Characteristics of Plantar Warts and Association With BMI: A Retrospective Case Series Study.
Li Z, Ma Y, Bian K, et al.
Skin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging (ISSI) 2025; (31(12)):e70303 doi:10.1111/srt.70303.
PMID: 41384642 - 2
Diagnostic accuracy of dermoscopy for 934 basal cell carcinomas: A single-center retrospective study.
Yuki A, Takatsuka S, Abe R, Takenouchi T
The Journal of dermatology 2023; (50(1)):64-71 doi:10.1111/1346-8138.16607.
PMID: 36229917 - 3
Dermoscopy-pathology relationship in seborrheic keratosis.
Minagawa A
The Journal of dermatology 2017; (44(5)):518-524 doi:10.1111/1346-8138.13657.
PMID: 28447350 - 4
Diagnostic Accuracy of Dermoscopic Characteristics in Cutaneous Squamous Cell Carcinoma: A Retrospective Analysis.
Zhang JL, Chen GZ, Wang D, et al.
Journal of skin cancer 2025; (2025()):9944605 doi:10.1155/jskc/9944605.
PMID: 41132512 - 5
Dermoscopy and Reflectance Confocal Microscopy Improves Accuracy in Differentiating Atypical Basal Cell Carcinoma from Seborrheic Keratosis and Vice Versa.
Morsia S, Pizzichetta MA, Kaleci S, et al.
Dermatology (Basel, Switzerland) 2025; (241(5-6)):453-462 doi:10.1159/000547590.
PMID: 40774163 - 6
Accuracy of dermoscopic criteria for the differential diagnosis between irritated seborrheic keratosis and squamous cell carcinoma.
Papageorgiou C, Spyridis I, Manoli SM, et al.
Journal of the American Academy of Dermatology 2021; (85(5)):1143-1150 doi:10.1016/j.jaad.2020.02.019.
PMID: 32068050 - 7
Dermoscopy of Basal Cell Carcinoma Part 3: Differential Diagnosis, Treatment Monitoring and Novel Technologies.
Wojtowicz I, Żychowska M
Cancers 2025; (17(6)) doi:10.3390/cancers17061025.
PMID: 40149358 - 8
Dermoscopy, Confocal Microscopy and other Non-invasive Tools for the Diagnosis of Non-Melanoma Skin Cancers and Other Skin Conditions.
Malvehy J, Pellacani G
Acta dermato-venereologica 2017; (Suppl 218()):22-30 doi:10.2340/00015555-2720.
PMID: 28676883 - 9
Uptake of an Acrochordon Incidentally Detected on 68Ga Prostate-Specific Membrane Antigen PET/CT.
Daglioz Gorur G, Hekimsoy T, Isgoren S, et al.
Clinical nuclear medicine 2017; (42(6)):461-462 doi:10.1097/RLU.0000000000001650.
PMID: 28368887 - 10
Plantar Verrucous Carcinoma Misdiagnosed as a Recalcitrant Wart: Diagnostic Pitfalls and Destructive Local Progression.
Ruiz Palafox CK, Flores Troche P, Espinoza Urzua I, et al.
Cureus 2026; (18(4)):e106660 doi:10.7759/cureus.106660.
PMID: 41959615 - 11
Oral verrucous carcinoma: A retrospective analysis for clinicopathologic features.
Sonalika WG, Anand T
Journal of cancer research and therapeutics 2016; (12(1)):142-5 doi:10.4103/0973-1482.172709.
PMID: 27072227 - 12
Should Margin Status of Biopsies Be Included in Dermatopathology Reports? Clinician Preferences and the Importance of Unambiguous Language.
Jacobsen E, Hippe DS, Lachance K, et al.
The American Journal of dermatopathology 2020; (42(3)):186-190 doi:10.1097/DAD.0000000000001553.
PMID: 31592864 - 13
Proliferative endophytic lesion of the maxilla: A diagnostic challenge.
Prasad RS, Moorthy A, Bhadranna A, Pai A
Journal of oral and maxillofacial pathology : JOMFP 2018; (22(Suppl 1)):S82-S86 doi:10.4103/jomfp.JOMFP_248_17.
PMID: 29491613 - 14
Utility of biopsy and frozen section in detecting malignancy within clinically suspicious verrucous growths: a retrospective study.
Joshi P, Bhawalkar A, Singhavi H, et al.
International journal of oral and maxillofacial surgery 2026; (55(8)):873-878 doi:10.1016/j.ijom.2026.03.005.
PMID: 41850910 - 15
Management of an Oral Squamous Cell Papilloma in an Unusual Maxillofacial Location: A Case Report.
P M, Shukla P, Saini N, et al.
Cureus 2026; (18(1)):e101197 doi:10.7759/cureus.101197.
PMID: 41669592 - 16
Oral verrucous hyperplasia versus oral verrucous carcinoma: A clinicopathologic dilemma revisited using p53 as immunohistochemical marker.
Sharma P, Wadhwan V, Aggarwal P, Sharma A
Journal of oral and maxillofacial pathology : JOMFP 2016; (20(3)):362-368 doi:10.4103/0973-029X.190902.
PMID: 27721598 - 17
An Unusual Presentation of Giant Fibroepithelial Polyp of the Vagina.
Daneshpajooh A, Mirzaei M, Iranpour M
Iranian journal of pathology 2021; (16(4)):456-460 doi:10.30699/IJP.2021.522689.2566.
PMID: 34567198 - 18
Lacrimal Caruncle Nevus with Papilloma.
Ishikawa E, Sabundayo MS, Takahashi Y, Kakizaki H
Case reports in ophthalmology 2017; (8(3)):535-538 doi:10.1159/000480725.
PMID: 29422855 - 19
Cutaneous verrucous carcinoma: A clinicopathological study of 21 cases with long-term clinical follow-up.
Ye Q, Hu L, Jia M, et al.
Frontiers in oncology 2022; (12()):953932 doi:10.3389/fonc.2022.953932.
PMID: 36313691 - 20
Papilloma and sebaceous gland hyperplasia of the lacrimal caruncle: a case report.
Miura-Karasawa M, Toshida H, Ohta T, Murakami A
International medical case reports journal 2018; (11()):91-95 doi:10.2147/IMCRJ.S162528.
PMID: 29731668 - 21
A Giant Fibroepithelial Polyp of the Nipple: A Case Report of a Rare Benign Tumor.
Al Sahee SS, Rait J, Hamidi-Latifi L
Cureus 2026; (18(5)):e108537 doi:10.7759/cureus.108537.
PMID: 42266315 - 22
Successful treatment of early cutaneous squamous cell carcinoma with hypofractionated radiation therapy in an African lion (Panthera leo).
Van der Weyden L, O'Dell N, Avenant A, et al.
Journal of the South African Veterinary Association 2021; (92(0)):e1-e6 doi:10.4102/jsava.v92i0.2134.
PMID: 34212735 - 23
Updates and Proposed Diagnostic Approach to Psoriasiform Dermatoses.
Shakshouk H, Erickson LA, Johnson EF, Lehman JS
Advances in anatomic pathology 2022; (29(5)):263-274 doi:10.1097/PAP.0000000000000333.
PMID: 35180737 - 24
Verrucous Carcinoma of the Lower Lip: A Rare Case Mimicking Benign Lesion.
Kim DG, Lee KA
Journal of clinical medicine 2025; (14(24)) doi:10.3390/jcm14248763.
PMID: 41464665
This page explains skin papilloma evaluation and biopsy terminology for informational purposes only and does not constitute medical advice. Your dermatologist or treating clinician should interpret your report and recommend follow-up.